64.11
前日終値:
$64.12
開ける:
$64.32
24時間の取引高:
62,312
Relative Volume:
0.11
時価総額:
$3.50B
収益:
$1.28B
当期純損益:
$-222.15M
株価収益率:
-15.68
EPS:
-4.09
ネットキャッシュフロー:
$145.52M
1週間 パフォーマンス:
+4.52%
1か月 パフォーマンス:
+1.50%
6か月 パフォーマンス:
+41.10%
1年 パフォーマンス:
+36.75%
Livanova Plc Stock (LIVN) Company Profile
LIVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LIVN
Livanova Plc
|
64.13 | 3.50B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
126.88 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.52 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.05 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.61 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
What risks investors should watch in LivaNova PLC stockInsider Selling Patterns & Affordable Investment Strategies - bollywoodhelpline.com
2026 world cup analysis insights: Is LivaNova PLC stock a dividend growth opportunity2026 world cup usa national team third place match key players high defensive line winner prediction insights - Улправда
In-Line Blood Monitoring Devices Market is expected to reach US$ - openPR.com
Market Fear: What is the fair value of LivaNova PLC stock nowTrade Risk Assessment & Fast Entry Momentum Alerts - moha.gov.vn
Electroceutical Devices Market to Reach USD 29,785.39 million - openPR.com
Published on: 2026-01-02 09:16:46 - moha.gov.vn
Precision Trading with Livanova Plc (LIVN) Risk Zones - Stock Traders Daily
LivaNova stock tests investor patience as Wall Street weighs turnaround against volatility - AD HOC NEWS
LivaNova CEO talks growth roadmap as company targets sleep apnea, depression therapies - MassDevice
LIVANOVA PLC (LIVN) - MSN
LivaNova PLC $LIVN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
LivaNova plc diskutieren - sharewise.com
LivaNova PLC (LIVN) - MSN
Voya Investment Management LLC Sells 21,244 Shares of LivaNova PLC $LIVN - MarketBeat
Vagus Nerve Stimulators Market Industry Analysis 2025-2032 - openPR.com
Adult And Pediatric Hemoconcentrators Market 2025-2032: - openPR.com
LivaNova to present at JP Morgan Healthcare Conference in January - MSN
LivaNova to Present at J.P. Morgan Healthcare Conference in January 2026 - BioSpace
Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova (LIVN)? - Sahm
LivaNova to Present at J.P. Morgan Healthcare Conference in January - Lelezard
LivaNova (STU:LIA) EV-to-OCF : 12.43 (As of Dec. 22, 2025) - GuruFocus
LIVN (LivaNova) EV-to-OCF : 13.15 (As of Dec. 23, 2025) - GuruFocus
How LivaNova PLC stock trades during market volatilityJuly 2025 Breakouts & Short-Term Trading Alerts - Улправда
Avoiding Lag: Real-Time Signals in (LIVN) Movement - Stock Traders Daily
Why LivaNova PLC stock could outperform in 20252025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Why LivaNova PLC stock is popular among millennials2025 Fundamental Recap & Risk Controlled Daily Plans - Улправда
LivaNova (NASDAQ:LIVN) Rating Increased to Strong-Buy at KeyCorp - MarketBeat
Is LivaNova PLC stock a dividend growth opportunity2025 Top Decliners & High Accuracy Investment Entry Signals - Улправда
LivaNova (NASDAQ:LIVN) Upgraded at Wall Street Zen - MarketBeat
Is LivaNova PLC (LIA) stock prepared for digital transitionEarnings Overview Summary & Safe Capital Growth Stock Tips - Улправда
Will LivaNova PLC (LIA) stock outperform value peersRate Cut & Precise Buy Zone Tips - Улправда
How interest rate cuts could boost LivaNova PLC stock2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
LivaNova (FRA:LIA) EV-to-OCF : 12.26 (As of Dec. 19, 2025) - GuruFocus
LIVN: Analyst Initiates Coverage with Overweight Rating and $81 PT | LIVN Stock News - GuruFocus
KeyBanc Initiates LivaNova at Overweight With $81 Price Target - marketscreener.com
LIVN Stock: KeyBanc Initiates Coverage with Positive Outlook - GuruFocus
At US$62.08, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List? - Yahoo Finance
Is LivaNova PLC stock a top momentum play2025 Retail Activity & Step-by-Step Trade Execution Guides - DonanımHaber
KeyBanc initiates Livanova stock with Overweight rating, cites growth outlook By Investing.com - Investing.com Nigeria
How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Gains Summary & Intraday High Probability Setup Alerts - Улправда
How buybacks impact LivaNova PLC stock valueEntry Point & Reliable Price Breakout Alerts - ulpravda.ru
[Form 4] LivaNova PLC Insider Trading Activity - Stock Titan
Fundamentals Check: Why LivaNova PLC stock could outperform in 2025Quarterly Performance Summary & Free Expert Verified Stock Movement Alerts - Улправда
Weekly Earnings: How LivaNova PLC (LIA) stock valuation compares with sectorWeekly Stock Summary & Pattern Based Trade Signal System - ulpravda.ru
Aug Analyst Calls: How buybacks impact LivaNova PLC stock valueWeekly Investment Recap & Community Driven Trade Alerts - Улправда
Mizuho Maintains LivaNova (LIVN) Outperform Recommendation - Nasdaq
Dir Podlogar Acquires 2,086 Of LivaNova PLC [LIVN] - TradingView — Track All Markets
LivaNova (NASDAQ:LIVN) Price Target Raised to $72.00 - MarketBeat
LIVN Analyst Rating: Mizuho Raises Price Target to $72.00 | LIVN Stock News - GuruFocus
Nomura Holdings Inc. Takes $3.92 Million Position in LivaNova PLC $LIVN - MarketBeat
Assessing LivaNova (LIVN)’s Valuation After Hiring ResMed Veteran to Lead Sleep Apnea Commercialization - Sahm
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
Livanova Plc (LIVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| PODLOGAR SUSAN M | Director |
Dec 15 '25 |
Option Exercise |
0.00 |
2,355 |
0 |
2,355 |
| Hutchinson Michael Damon | SVP, CLO and Company Secretary |
Dec 15 '25 |
Option Exercise |
0.00 |
2,254 |
0 |
7,920 |
| Story Brooke | Director |
Nov 18 '25 |
Sale |
53.94 |
250 |
13,485 |
6,232 |
大文字化:
|
ボリューム (24 時間):